These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6770126)

  • 1. A comparative study of the effectiveness of 'standard' and 'AFIP' typhoid vaccines.
    Burney MI; Ahmed A; Karamat KA
    J Pak Med Assoc; 1980 Mar; 30(3):66-8. PubMed ID: 6770126
    [No Abstract]   [Full Text] [Related]  

  • 2. [Means of the standardization of the experimental conditions for the verification of the effectiveness of typhoid vaccines].
    LEONT'EVA NF
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Aug; 30():54-7. PubMed ID: 14415841
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunizing capacity of a five years old dried typhoid vaccine.
    Dimache G; Dimache V; Croitoru M
    Arch Roum Pathol Exp Microbiol; 1981; 40(1):55-9. PubMed ID: 7185349
    [No Abstract]   [Full Text] [Related]  

  • 4. [Typhoid vaccination and typhoid immunology].
    Günther O
    Dtsch Med Wochenschr; 1970 May; 95(21):1186-9. PubMed ID: 5444148
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of methods of evaluation of the potency of typhoid vaccines].
    Cabrera R; González Pacheco M; Pérez Miravete A
    Rev Invest Salud Publica; 1972; 32(3-4):187-93. PubMed ID: 4677604
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological standardization of typhoid vaccines by antibody measurements.
    SPAUN J
    Acta Pathol Microbiol Scand; 1956; 39(6):469-80. PubMed ID: 13381494
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status of typhoid fever vaccination].
    Mebel S; Rustenbach S
    Z Arztl Fortbild (Jena); 1973 Jan; 67(1):17-21. PubMed ID: 4580180
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental method using bacteremia as an index to evaluate the potency of typhoid vaccines].
    Cabrera Contreras R; González Pacheco M; Pérez-Miravete A
    Rev Invest Salud Publica; 1973; 33(3-4):83-97. PubMed ID: 4793810
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolution of the typhoid immunity along one year after intradermal vaccination.
    Dimache G; Croitoru M; Ciordaş C; Velea V
    Arch Roum Pathol Exp Microbiol; 1986; 45(2):147-52. PubMed ID: 3800632
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
    Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
    N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disappearance rate from the circulation of normal & immune rabbits of typhoid vaccine labeled with P32 & injected by intravenous route].
    PAOLETTI A; BUONINCONTRO L
    Ann Sanita Pubblica; 1958; 19(5):1019-31. PubMed ID: 13606657
    [No Abstract]   [Full Text] [Related]  

  • 13. [Should typhoid-paratyphoid vaccination be continued?].
    Mercier P; Antoine HM
    Bull Acad Natl Med; 1979 May; 163(5):446-50; discussion 450-1. PubMed ID: 15648337
    [No Abstract]   [Full Text] [Related]  

  • 14. Duration of postvaccination antityphoid immunity according to the results of strictly controlled field trials.
    Hejfets LB
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(2):154-65. PubMed ID: 5817422
    [No Abstract]   [Full Text] [Related]  

  • 15. Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
    Pulickal AS; Pollard AJ
    Expert Rev Vaccines; 2007 Jun; 6(3):293-5. PubMed ID: 17542742
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The problem of control of anti-typhoid vaccines. V. The immunogenic value of antityphoid vaccines in relation to the antigenic structure of the strains used in their preparation].
    Gabbrielli G; Buzzanca E
    Boll Soc Ital Biol Sper; 1968 Apr; 44(8):725-8. PubMed ID: 5698500
    [No Abstract]   [Full Text] [Related]  

  • 18. [Demonstration of effectiveness of the oral typhoid vaccine. Evidence with help of allergocytolysis].
    Stickl H; Lohmüller G
    Munch Med Wochenschr; 1969 Apr; 111(15):863-9. PubMed ID: 5409219
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Household demand for typhoid fever vaccines in Hue, Vietnam.
    Do GC; Whittington D; Le TK; Utomo N; Nguyen TH; Poulos C; Dang TD; Kim D; Nyamete A; Acosta C
    Health Policy Plan; 2006 May; 21(3):241-55. PubMed ID: 16581824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.